Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Cancer Problems with Hysterectomy Morcellators May Have Slipped Through Regulatory Gaps May 4, 2015 Irvin Jackson Add Your Comments Amid continuing concerns over the failure to recognize that women may face a risk of serious cancer problems following a laparoscopic hysterectomy involving morcellation, some law makers are pushing the FDA to overhaul its “fast-track” 510(k) medical device approval process. In recent months, Senator Robert Casey and Representative Michael Fitzpatrick, both of Pennsylvania, have been pressuring the FDA to take a closer look at potential failings of the program, which they say have allowed morcellators and other devices with potentially deadly side effects to go on the market without thorough testing. Morcellators are medical devices used in recent years during minimally invasive hysterectomy and myomectomy procedures, allowing the doctor to cut up and remove the uterus or uterine fibroids through a small incision in the abdomen. Learn More About Hysterectomy Morcellation Cancer Lawsuits Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Hysterectomy Morcellation Cancer Lawsuits Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Years after the devices hit the market and became widely used within the medical community, morcellators have been linked to a risk of deadly problems for some women who have hidden or unsuspected cancer, potentially spreading leiomyosarcoma, endometrial stromal sarcoma or other cancerous tissue contained within the uterus. The rapid dissemination of the cancer to other areas of the body may greatly impact the woman’s chances for long-term survival and impact their overall quality of life. Last month, Congressman Fitzpatrick addressed the FDA at a workshop on post-market surveillance of medical devices, indicating that the agency needs to do more to prevent devices like morcellators from slipping through regulatory gaps in the approval process. In a recent letter, Senator Casey asked what the FDA was doing to address issues with manufacturers failing to report adverse events associated with their products and how the agency decides when it needs to force a medical device recall or let the manufacturer do so on its own. The 510(k) program allows medical devices to be approved with little to no pre-market testing requirements. In most cases, the manufacturer just needs to show that the devices are “substantially equivalent” to devices already on the market. However, the definition of “substantially equivalent” is vague, with many manufacturers seeking approval for devices under the program while at the same time boasting that the devices are new and innovative, which many critics say means they cannot be equivalent to devices already on the market. The FDA has not responded to the inquiries publicly, but according to a story on Medscape.com, the agency has been in private contact with both lawmakers’ offices. Hysterectomy Morcellator Cancer Problems Although the FDA approved the first electronic morcellator in 1993, the agency did not issue warnings about the cancer risk following a hysterectomy or myomectomy until April 2014. At that time, the agency announced that it was investigating the potential for cancer problems, estimating that one out of every 350 women undergoing a laparoscopic hysterectomy or myomectomy may have unsuspected sarcoma. An FDA advisory panel was convened last summer to evaluate the available data on the controversial devices, which resulted in a determination that there is no way to make power morcellators safer. However, the panel was split on whether to recommend morcellators be recalled or that stronger warnings be placed on the devices. In a widely criticized move, the FDA announced in November that it will allow hysterectomy morcellators to remain on the market with substantially stronger warnings about the risk of cancer and more limited indications for appropriate use of the devices. Many hospitals have already announced that they will no longer perform a hysterectomy with morcellation, and many experts agree that the vast number of prior procedures performed involving the device are no longer appropriate. Manufacturers of the devices now face a growing number of hysterectomy morcellation cancer lawsuits filed on behalf of women diagnosed with advanced stage cancer after the device was used, alleging that inadequate warnings were provided for consumers and the medical community. Tags: Cancer, Congress, Ethicon, Hysterectomy, Johnson & Johnson, Leiomyosarcoma, Morcellation, Uterine Cancer, Uterine Fibroid Removal More Morcellation Lawsuit Stories FDA Issues New Guidelines, Safety Communication On Use Of Power Morcellators February 26, 2020 Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study September 30, 2019 CDC Weighs New Guidelines For Gynecologists For Detecting Uterine Cancer May 11, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study September 30, 2019
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)